4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001628280-25-048858
Chief Financial Officer sold 1,303 shares at $6.49 ($8,456)
- Chief Financial Officer acquired 3,605 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelly John Alexander Chief Financial Officer | 2025-11-02 | Option exercise 10b5-1 | +3,605 | 78,601 | D | ||
| Kelly John Alexander Chief Financial Officer | 2025-11-03 | Sale 10b5-1 | −1,303 | $6.49 | $8,456 | 77,298 | D |
| Derivatives | |||||||
| Kelly John Alexander Chief Financial Officer | 2025-11-02 | Option exercise · Restricted Stock Units 10b5-1 | −3,605 | 0 | D | ||
| Open-market sales · 1,303 sh · avg $6.49 · $8,456 | |||||||
Loading xslF345X05/wk-form4_1762290943.xml…